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acute exacerbations of COPD.
Subjects and methods: This was a cross-sectional study involving 105 patients hospitalized with
exacerbations of COPD. Clinical and hematological parameters on admission were collected. Mul-
tislice computed tomographic pulmonary angiography (CTPA) and ultrasonographic examination
of lower limbs, for pulmonary embolism and deep vein thrombosis respectively were done. Wells
and Geneva scores were calculated.
Results: This study was conducted on 105 COPD patients with acute exacerbations. All of them
were males with mean age 49.3 + 8.43. Pulmonary embolism was found in 28.6% of COPD
patients who were deﬁnitely diagnosed by CTPA while DVT was found in 26.7% of positive cases
of pulmonary embolism detected by venous duplex. Wells and Geneva scores were calculated, high
probability Wells score was found in 83.3% while Geneva score was likely in 90% of COPD
patients proved to have pulmonary embolism. D-dimer and CBC were done; D-dimer was found
negative in 90.0% in patients proven not to have pulmonary embolism while was positive in
100% of the diagnosed patients. Regarding CBC; polcythemia was found in 73.3% of diagnosed
cases.
Conclusion: VTE appeared to be a common problem in COPD patients with exacerbations. The
role of CTPA is the cornerstone in the diagnosis of pulmonary embolism. DVT of lower limbs was
not essential in all cases of proven pulmonary embolism. Serum D-dimer, Wells criteria and Geneva
score are useful bedside criteria that may help to assess the occurrence of VTE in such patients.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis.Open access under CC BY-NC-ND license.01223968966.
mail.com (H. Moussa).
e Egyptian Society of Chest
g by Elsevier
ng by Elsevier B.V. on behalf of T
://dx.doi.org/10.1016/j.ejcdt.2013.0Introduction
COPD is a major health burden worldwide. It is the fourth
leading cause of mortality, accounting for >3 million deaths
annually; and by 2020, COPD will be the third leading cause
of death, trailing only ischemic heart disease and stroke [1].he Egyptian Society of Chest Diseases and Tuberculosis.
7.001
Table 2 Wells score.
Points of wells score
Clinically suspected deep vein thrombosis (DVT) 3
Alternative diagnosis less likely than PE 3
Rapid heart rate 1.5
Immobilization within past 4 weeks 1.5
History of DVT 1.5
Hemoptysis 1
Malignancy 1
A total score greater than 6 indicates a high probability of a PE, a
score between 2 and 6 moderate probability and a score below 2 low
probability [25].
558 M.M. Kamel et al.Most COPD related-deaths occur during periods of exacerba-
tions. Sapey and Stockley estimated that 50–70% of all COPD
exacerbations are precipitated by an infectious process, while
10% are due to environmental pollution. Up to 30% of exac-
erbations are caused by an unknown etiology [2]. Exacerba-
tions of COPD are episodes of acute deterioration in
respiratory symptoms [3] that are accompanied by physiologi-
cal changes [4], and associated with increase in airway and sys-
temic inﬂammation [5]. These episodes are responsible for
considerable morbidity and mortality, especially in patients
with more severe COPD [6]. There is consequently much inter-
est in understanding the underlying pathophysiology of exac-
erbations and determining their triggers, so that appropriate
interventions can be designed to prevent these events, reduce
their severity and thus improve health status [7].
Acute pulmonary embolism (PE) and deep venous throm-
bosis (DVT) are manifestations of the overall disease known
as venous thrombo-embolism (VTE) [8]. Chronic obstructive
pulmonary disease (COPD) is a moderate predisposing factor
for VTE, principally when associated with hospitalization [9].
Post hoc analyses of administrative healthcare databases using
diagnostic codes suggest that the increased risk of VTE in
COPD patients may be predominantly manifested in the form
of PE rather than DVT [10]. An increased expression of VTE
as PE in COPD patients may be problematic since the mortal-
ity of COPD patients with PE is particularly high [11], and
COPD has been integrated in prognostic scores such as the
Simpliﬁed Pulmonary Embolism Severity Index [12]. COPD
has also been associated with inappropriate management in
the case of suspected PE [13] and the suggestion of PE may
be challenging in COPD patients [14] because of the similari-
ties in symptoms. The former consideration may particularly
apply during COPD exacerbation [15], a situation in which
undiagnosed PE was found in an autopsy study in up to
30% of COPD patients who died [16]. Finally, COPD has been
associated with an increased risk of unsuspected fatal PE [17].
Conﬁrming the increased rate of PE in COPD patients, this
should prompt clinicians to enhance PE suspicion in COPD
patients at risk for VTE [18].
Sidney et al. [19] suggested that patients with COPD have
approximately twice the risk of pulmonary embolism (PE)Table 1 The simpliﬁed Geneva score.
Variable Score
Age > 65 1
Previous DVT or PE 1
Surgery or fracture within 1 month 1
Active malignancy 1
Unilateral lower limb pain 1
Hemoptysis 1
Pain on deep vein palpation of lower
limb and unilateral edema
1
Heart rate 75 to 94 bpm 1
Heart rate greater than 94 bpma +1
Patients with a score of 2 or less are considered unlikely to have a
current PE. Authors suggest that the likelihood of patients having a
PE with a simpliﬁed Geneva score less than 2 and a normal D-
dimer is 3%.[24].
a Heart rates of 75 to 94 bpm receive 1 point, while heart rates
higher than 94 bpm receive a further point (i.e. 2 points in total).and other venous thrombo-embolic events rather than those
without COPD. Since thrombo-embolic events can lead to
cough and dyspnea (just like infectious events), PE may be
another common cause of COPD exacerbations [20]. How-
ever dissimilar to infectious etiologies, which are effectively
treated by antimicrobials and systemic corticosteroids,
thrombo-embolic diseases require anticoagulant therapy
and signiﬁcant delays in treatment are associated with poor
outcomes [21]. Owing to multiple perfusion and ventilation
abnormalities frequently observed in COPD lungs (even
the absence of VTE), noninvasive diagnosis of PE using
imaging modalities was a signiﬁcant challenge until quite re-
cently. With the advent of contrast-enhanced multi-detector
CT angiography, it is now possible to reliably diagnose PE
in COPD subjects with minimal discomfort or risk to the
patients [22].
Aim of work
To determine the prevalence of venous thrombo-embolism in
COPD patients suffering from acute exacerbations requiring
hospitalization.
Subjects and methods
This was a cross-sectional study involving 105 patients hospi-
talized with exacerbations of COPD. It was carried out in Kasr
El-Aini Hospital, Faculty of Medicine, Chest and Radiology
departments during the period from June 2011 till June2012.
All patients underwent the following:
1. Detailed medical history and epidemiological data.
2. Detailed physical examination
3. Analysis of resting arterial blood gas levels while breathing
room air.
4. Detailed biochemical and hematological parameters,
including D-dimer levels, were performed immediately. D-
dimer test measures the levels of a protein that is produced
when blood clots are broken down by the body. A negative
D-dimer test is a good assurance that you do not have a
DVT or pulmonary embolism and do not require treatment
for these conditions. However, a positive D-dimer test is
not enough to diagnose blood clots, and further tests will
be needed [23].
5. Conventional chest radiographs were done.
6. Calculation of Geneva and Wells scores (Tables 1 and 2).
Prevalence of venous thrombo-embolism in acute exacerbations of chronic obstructive pulmonary disease 5597. Bilateral lower limb venous imaging (duplex and CTV); to
detect venous thrombi in lower limbs. For detection of
DVT, starting from the subdiaphragmatic level to the leg
level, all veins were scanned 180 s after contrast material
injection for CT pulmonary angiography, with a slice thick-
ness of 5 mm and a slice interval of 5 mm. The diagnostic
criteria for DVT on CT venography were the presence of
an intra luminal ﬁlling defect in an opaciﬁed vein, or a
localized non-opaciﬁed venous segment on at least two con-
secutive axial CT images if the vein distal and proximal to
the non-opaciﬁed segment was opaciﬁed. Doppler ultra-
sonography (ATL-HDI 3500; ATL, Seattle, WA, USA)
was also utilized as a standard method in the identiﬁcation
of thrombi in the lower extremities. From the common fem-
oral vein to the popliteal vein of both lower extremities
were examined using the venous compression technique
with ultrasonography. No compressibility of the veins
was considered to indicate DVT (Fig. 1).
8. Dynamic multi-slice computed tomography (MSCT) scan-
ning (CT angiography) to reveal thrombus formation in
the lower extremities and emboli in the lungs (light speed
CT; GE medical systems, Milwaukee, WI, USA) within
24 h following hospitalization. CT scans of the thorax wereFigure 1 CTV and Doppler of lower limbs (a) CTV axial sections
thrombus involving left common femoral vein, superﬁcial femoral vei
seen in left popliteal artery (black arrow) (b): Volume rendered images
defect in the region of left common femoral vein, superﬁcial femoral
arrow) (c): Doppler USG of same patient at level left upper and mid
popliteal vein with absence of color ﬁlling. Left popliteal artery (blackperformed during breath-holding, scanners are used to
acquire the images of the thorax in a caudal-cranial direc-
tion. The caudal-cranial direction is used because most
emboli are located in the lower lobes and, if the patient
breathes during image acquisition, there is more excursion
of the lower lobes compared with the upper lobes. For IV
access, the antecubital vein and an 18- or 20-gauge catheter
is preferred with an injection of 130 mL nonionic contrast
material (iopromide; Ultravist-300; Schering, Baar, Swit-
zerland) for patients with a body mass index of
630 kg m2, with a power injector at 3 mL s1 and using
a slice thickness of 3 mm, tube voltage of 120 kV and tube
current of 240 mA. The injection volume of the contrast
material was increased to 150 mL for patients with a body
mass index of >30 kg m2, and tube voltage to 140 kV.
The reconstruction interval was 2 mm. PE was diagnosed
if the contrast material outlined an intra-luminal defect,
or if the vessel was totally occluded by a low-attenuation
material. Multiplanar reformation images through the lon-
gitudinal axis of a vessel can be used to overcome some of
the difﬁculties encountered with axial-orientated images of
obliquely or axially orientated arteries. Also, reformatted
images can help to differentiate between some patient,at level of upper thigh, mid thigh and popliteal fossa showing
n and popliteal vein (white arrows). In addition, thrombus is also
in anterior and posterior view in the same patient showing ﬁlling
vein, popliteal vein (white arrows) and left popliteal artery (black
thigh, and popliteal fossa showing thrombus ﬁlling left SFV and
arrow) also showed no color ﬁll in (thrombus) [26].
560 M.M. Kamel et al.technical, anatomic, and pathologic factors that mimic
pulmonary embolism and true pulmonary embolism
(Figs. 2–4).
Results
Data were statistically described in terms of mean ± stan-
dard deviation (± SD), or frequencies (number of cases)
and percentages when appropriate. A comparison of numer-
ical variables between the study groups was done using Stu-
dent t test for independent samples. For comparing
categorical data, Chi square (v2) test was performed. Exact
test was used instead when the expected frequency is less
than 5. Accuracy was represented using the terms sensitiv-
ity, speciﬁcity, +ve predictive value, ve predictive value,
and overall accuracy. P Values less than 0.05 was consid-
ered statistically signiﬁcant. All statistical calculations were
done using computer programs SPSS (Statistical Package
for the Social Science; SPSS Inc., Chicago, IL, USA)
version 15 for Microsoft Windows.
This study involved 105 male patients who were admit-
ted with acute exacerbation of COPD. The ages ranged
from 35–74 years old with a mean age of 49.3 + 8.43
(Tables 3–8).Figure 2 (a) the left main pulmonary artery shows a sizable hypoden
lobe branch. (b) Axial Images showing bilateral lower lobes emboli comStatistical methods were done to ﬁnd correlations between
patients with venous thrombo-embolism (as detected by CT-
pulmonary angiography; most accurate method of detection)
and other methods of diagnosis (Table 9–14).
Discussion
The chronic obstructive pulmonary disease (COPD) patient
presenting with acute dyspnea can be a diagnostic challenge
in both the outpatient and inpatient settings. Many cardiopul-
monary diseases, including acute pulmonary embolism (PE),
are worsened or masked by the presence of COPD. While diag-
nostic tests such as B-type natriuretic peptide have led to dif-
ferentiating dyspnea in heart failure from COPD
exacerbation, there are no proven clinical criteria to help delin-
eating acute pulmonary embolism from COPD. This is attrib-
utable to the overlap and non-speciﬁcity of clinical features
common to both diseases. The presentation of pulmonary
embolism is similarly subtle with non-speciﬁc clinical features
such as acute dyspnea, tachycardia, and pleuritic chest pain.
While COPD remains a clinical diagnosis, PE requires objec-
tive conﬁrmation of clots by an imaging study to warrant
appropriate anticoagulation therapy. When recognizing that
the mortality of untreated PE may be as high as 25%, it is cru-
cial to incorporate PE into the differential diagnosis of ase ﬁlling defect ﬁlling the distal half and extending within the lower
pletely or partially occluding the lumen (arrow and arrow heads).
Prevalence of venous thrombo-embolism in acute exacerbations of chronic obstructive pulmonary disease 561COPD exacerbation, and instructive to review the incidence of
PE in COPD patients in the reported literature [27].
Thrombo-embolism represents a spectrum of disease, rang-
ing from deep venous thrombosis (DVT) to PE and infarcts.
Our study was done on patients with acute exacerbations of
COPD. All of them were males with age ranging from 35 to
74 years with mean age 49.3 + 8.43. This mean age was similar
to most of the studies addressing this issue as that done by
Gershon et al. [28]. The predominance of males and older pa-
tients in the COPD group is easily understood as the preva-
lence of COPD increases with age and more common in
males. Our study shows that the prevalence of pulmonary
embolism among patients with acute exacerbations of COPD
is 28.6% being surely diagnosed by CTPA. DVT prevalence
diagnosed by lower limb venous duplex is 10.5%. Other diag-
nostic tools may help in the diagnosis of pulmonary embolism
as D-dimer which is positive in all cases of pulmonary embo-
lism (sensitivity 100%). Not only this, but there are clinicalFigure 3 (a) showed bilateral pulmonary embolism more on left side
branch ﬁlling defect, arrow (c) axial CT image of right lower lobe witscores which may help in the diagnosis of pulmonary embolism
namely Geneva and Wells scores. In our study, Geneva score is
signiﬁcantly associated (likely incidence of PE) in 90% of cases
with proven pulmonary embolism and was unlikely in 88% of
cases proved not to have PE while Wells score shows a high
probability in 83.3% of proven cases. The presence of polycy-
themia is a constant ﬁnding in 73.3% of cases with positive
pulmonary embolism highlighting a signiﬁcant laboratory cri-
terion in patients with proven pulmonary embolism.
The prevalence of PE in patients with COPD is important
because of combined morbidity and mortality. In a follow-
up of 1487 patients from the Prospective Investigation of Pul-
monary Embolism Diagnosis (PIOPED) study, Carson et al.
[29] found an adjusted estimated relative risk of death at one
year with COPD and PE of 1.94, compared with 1.1 for pa-
tients with PE alone. The one year mortality of those with
COPD and PE was 53.3%, in contrast to 15% of those with
PE alone [27]. As there is clinical difﬁculty in diagnosing PEwith pulmonary infarcts. (b) reformatted image of left lower lobe
h distal lung infarction and minimal pleural effusion.
Figure 4 The branches of right lower lobe are variably attenuated and occluded.
Table 3 CBC in patients with acute exacerbation of COPD.
CBC Frequency Percent
Anemia 7 6.7
Normal 55 52.4
Polycythemia 43 41.0
Total 105 100.0
Table 4 D-dimer in patients with acute exacerbation of
COPD.
D-dimer Frequency Percent
Negative 68 64.8
Positive 37 35.2
Total 105 100.0
Table 5 Geneva score in patients with acute exacerbation of
COPD.
Geneva score Frequency Percent
Likely 36 34.3
Unlikely 69 65.7
Total 105 100.0
Table 6 Wells score in patients with acute exacerbation of
COPD.
Wells score Frequency Percent
Low/Moderate 80 76.2
High 25 23.8
Total 105 100.0
Table 7 Duplex in patients with acute exacerbation of COPD.
Duplex Frequency Percent
Negative 94 89.5
Positive 11 10.5
Total 105 100.0
Table 8 Multislice CT pulmonary angiography results
(CTPA) in patients with acute exacerbation of COPD.
CTPA-PE Frequency Percent
Negative 75 71.4
Positive 30 28.6
Total 105 100.0
562 M.M. Kamel et al.in the setting of COPD as was described by Sharma and Sasa-
hara [30] it is crucial to incorporate PE into the differential
diagnosis of a COPD exacerbation. Our study showed that
the prevalence of PE in cases of COPD exacerbations was
28.6%, similarly as Tillie-Lebond et al. [31] who reported25% prevalence of pulmonary embolism in patients with
COPD hospitalized with severe exacerbations. In contrast,
Rutschmann et al. [32] concluded that the prevalence of pul-
monary embolism was 6.2% in patients with COPD with clin-
ical suspicion, and only 1.3% where there was no clinical
Table 9 Results of CBC in relation to CTPA ﬁndings.
CTPA-PE Total
Negative Positive
CBC Anemia Count 7 0 7
% Within CTPA-PE 9.3% 0.0% 6.7%
Normal Count 47 8 55
% Within CTPA-PE 62.7% 26.7% 52.4%
Polycythemia Count 21 22 43
% Within CTPA-PE 28.0% 73.3% 41.0%
Total Count 75 30 105
% Within CTPA-PE 100.0% 100.0% 100.0%
P-Value: 0.000, sensitivity: 73.33, speciﬁcity: 72.0.
Table 10 Results of D-dimer in relation to CTPA ﬁndings.
CTPA-PE Total
Negative Positive
D-dimer Negative Count 68 0 68
% Within CTPA-PE 90.7% 0.0% 64.8%
Positive Count 7 30 37
% Within CTPA-PE 9.3% 100.0% 35.2%
Total Count 75 30 105
% Within CTPA-PE 100.0% 100.0% 100.0%
P-Value: 0.000, sensitivity: 100.00, speciﬁcity: 90.67.
Table 11 Geneva score in relation to CTPA ﬁndings.
CTPA-PE Total
Negative Positive
Geneva Likely Count 9 27 36
% Within CTPA-PE 12.0% 90.0% 34.3%
Unlikely Count 66 3 69
% Within CTPA-PE 88.0% 10.0% 65.7%
Total Count 75 30 105
% Within CTPA-PE 100.0% 100.0% 100.0%
P-Value: 0.000, sensitivity: 90.00, speciﬁcity: 88.00.
Table 12 Wells Score in relation to CTPA ﬁndings.
CTPA-PE Total
Negative Positive
Wells Low/Moderate Count 75 5 80
% Within CTPA-PE 100.0% 16.7% 76.2%
High Count 0 25 25
% Within CTPA-PE 0.0% 83.3% 23.8%
Total Count 75 30 105
% Within CTPA-PE 100.0% 100.0% 100.0%
P-Value: 0.000, sensitivity: 83.33, speciﬁcity: 100.
Prevalence of venous thrombo-embolism in acute exacerbations of chronic obstructive pulmonary disease 563suspicion of pulmonary embolism and this was owed to the
patients selected who were in the emergency department.
Regarding D-dimer, it was found that it is negative in
90.7% of cases without pulmonary embolism and positive in100% of positive cases of pulmonary embolism. Hartmann
et al. [33] Moua and Wood [27] similarly reported that D-di-
mer is the preferred diagnostic tool in the outpatient setting
and emergency department for DVT and PE and also that
Table 13 Lower limb venous duplex results in relation to CTPA ﬁndings.
CTPA-PE Total
Negative Positive
Duplex Negative Count 72 22 94
% Within CTPA-PE 96.0% 73.3% 89.5%
Positive Count 3 8 11
% Within CTPA-PE 4.0% 26.7% 10.5%
Total Count 75 30 105
% Within CTPA-PE 100.0% 100.0% 100.0%
P-Value: 0.002, sensitivity: 26.67, speciﬁcity: 96.00.
Table 14 Age characteristics in COPD patients with and without pulmonary embolism.
CTPA-PE N Mean Standard deviation Standard error of mean
Age Negative 75 50.52 8.934 1.032
Positive 30 46.27 6.153 1.123
P-Value: 0.007.
564 M.M. Kamel et al.COPD had no inﬂuence on the diagnostic accuracy of the test
for thrombo-embolic disease. A systematic review found a neg-
ative D-dimer to be as diagnostically useful as a normal lung
perfusion scan or negative duplex ultrasonography in the set-
ting of low pretest probability [34].
The majority of pulmonary emboli (87–97%) originate
from the lower extremities, particularly the deep veins of the
thigh. Our study showed that lower limb duplex was positive
in 26.7% of positive cases and negative in 96% of cases with-
out pulmonary embolism which means that thrombo-embo-
lism had occurred as a result of other causes related to
COPD itself i.e. hypoxemia and polycythemia which in turn
leads to hypercoaguable state. Similarly, among 29 patients
with COPD exacerbations, Winter et al. [35] had found 13 pa-
tients with DVT; two of which were later found to have PE
postmortem. Of these patients, none presented with clinical
signs of DVT. Also Erelel et al. [36] followed up 56 patients
with hospitalized COPD and detected DVT by ultrasound in
eight. Five were subsequently diagnosed with pulmonary
embolism by high probability V/Q scanning. Ambrosetti
et al. [37] suggested 10% of patients with COPD have concom-
itant DVT, though this number may far underestimate actual
prevalence. The risk of DVT appears increased due to poor
mobility with worsening respiratory status, chronic steroid
use, and active smoking [36].
Our study showed that pulmonary embolism was found in
28.6% of COPD patients as diagnosed by CTPA and negative
in 71.4%. However, Rutschmann et al. [32] found only four
cases of computed tomography (CT) proven PE out of 123
consecutive patients presenting with COPD exacerbation, rep-
resenting a prevalence of 3.3%.
During our study, we found that polycythemia was present
in 73.3% of proven cases of PE. Biswas et al. [38] showed that
hypoxemia stimulates bone marrow leading to increase in red
cells which in turn leads to polycythemia. This may explain the
hypercoagulable state leading to thrombotic events in a large
proportion of our patients.Because symptoms of PE may be non-speciﬁc, clinical pre-
diction rules are used to reduce the need for imaging. Our
study showed that the likely high probability Geneva score
was signiﬁcantly associated with 90% of positive cases. On
the other hand; Gunen et al. [39] had found it signiﬁcant with
33% of patients with pulmonary embolism only. In the study
done by Monreal et al. [40], Geneva score was positive in
11% of COPD patients with pulmonary embolism. However,
a direct comparison of the results may not be appropriate
due to major methodological variations between the studies
and differences between the patient populations. Wells criteria
was signiﬁcantly high in 83.3% of COPD cases with
pulmonary embolism with speciﬁcity 100.00 i.e. there was
never a high probability of the Wells score in patients with neg-
ative CTPA ﬁndings for Pulmonary Embolism. These results
were similar to those in the study done by Gunen et al. [39].
Of the studies that were assessed, only one study applied a
validated clinical prediction probability of PE (i.e., a Geneva
score) to determine the pretest probability of PE. It found that
even patients in low-risk category (a Geneva score 4) had a
substantive prevalence of PE (approximately 9%), although
the prevalence was lower compared to those in high-risk cate-
gory (a score 9; 46% prevalence). These data suggest that the
Geneva risk scores may not be optimal in risk stratifying
COPD patients for PE. Alternative instruments include the
Wells criteria and the decision rule had been developed by
Miniati et al. [41], but none of these have been well validated
in COPD patients during exacerbations. Despite these short-
comings, the judicious use of these validated instruments in
the context of a careful clinical and laboratory assessment
may be helpful in avoiding unnecessary imaging studies.
In conclusion, patients with COPD exacerbations appear to
experience PE at high rates. Since the presenting symptoms,
signs and laboratory data are similar in COPD patients with
and without VTE, it may not be easy to exclude VTE in the
differential diagnosis. So, COPD patients hospitalized with
an exacerbation of any origin should be evaluated for throm-
Prevalence of venous thrombo-embolism in acute exacerbations of chronic obstructive pulmonary disease 565bo-embolic events unless serum D-dimer level and Wells crite-
ria indicate otherwise.Conﬂict of interest
The authors declare that there are no conﬂict of interest.
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